Official Title
Retraining of the Amygdala and Insula for the Treatment of Persistent Covid
Brief Summary

Prolonged COVID, also known as post-COVID or Sar-CoV-2 infection with post-acutesequelae, refers to a set of multi-organ symptoms that persist in patients who havesuffered SARS-CoV-2 infection, even after of the acute phase of the disease.Approximately 10% of people experience this set of symptoms after their acute COVID hasresolved. Such symptoms may include respiratory problems, myalgia, extreme fatigue,moodiness, cognitive impairment, and difficulty sleeping.Psychological therapies, such as mindfulness, have already demonstrated theireffectiveness in pathologies of this type, improving mental health and physical function,as well as reinforcing acceptance and reducing symptoms. Specifically, amygdala-insulatraining was originally designed for patients with chronic fatigue syndrome as a methodof reducing chronic over-sensitization and heightened fear response of the amygdala,which may be behind some of the symptoms related to both with this pathology as withfibromyalgia.A lot of research is currently being done on different types of treatments such aspharmaceutical, biological, dietary, homeopathic and rehabilitation for the treatment ofpersistent COVID; however, an effective treatment has not yet been found. Therefore, thisstudy aims to evaluate the impact of a retraining intervention of the amygdala and insulafor the improvement of the quality of life of patients with persistent COVID.

Detailed Description

Not Provided

Recruiting
Mental Health Wellness

Behavioral: AIR + Mindfulness

AIR + Mindfulness program consists of 8 sessions of 120 minutes/session (10-12 people)
Written material and sound recordings will be offered as support elements. The estimated
duration of the program is two months.

Behavioral: Relaxation condition

Relaxation program consists of 8 sessions of 120 minutes/session (10-12 people) Written
material and sound recordings will be offered as support elements. The estimated duration
of the program is two months.

Eligibility Criteria

Inclusion Criteria:

- Age: 18-30 years old.

- Grant informed consent.

- Diagnosis of persistent COVID by primary care physicians.

Exclusion Criteria:

- Age: <18 years old

- Serious medical or psychiatric illnesses

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Spain
Locations

Department of Psychiatry. Miguel Servet University Hospital
Zaragoza, Spain

Investigator: Javier García Campayo
Contact: 976 50 65 78
investigaprimaria@gmail.com

Investigator: Javier García Campayo

Contacts

Javier García Campayo, PhD
+34976506578
jgarcamp@gmail.com

Virginia Gasión
34976506578
virginia.gasion@gmail.com

Not Provided

Hospital Miguel Servet
NCT Number